Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

IoM Supplement Framework Should Reflect “Relative” Safety – CHPA

This article was originally published in The Tan Sheet

Executive Summary

Dietary supplement safety should be treated as a "relative concept" under the Institute of Medicine's proposed scheme for a systematic approach to evaluating supplements, CHPA Senior VP-Director of Science & Technology William Soller, PhD, suggested July 24
Advertisement

Related Content

CRN Structure/Function Claim Substantiation Document Under Development
CRN Structure/Function Claim Substantiation Document Under Development
CRN Structure/Function Claim Substantiation Document Under Development
Three-Step Supplement Safety Review Model Proposed by IoM
Three-Step Supplement Safety Review Model Proposed by IoM
Three-Step Supplement Safety Review Model Proposed by IoM
Three-Step Supplement Safety Review Model Proposed by IoM
Multi-Ingredient Supplements Warrant Priority Safety Review - Whitehall Rep

Topics

Advertisement
UsernamePublicRestriction

Register

PS094332

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel